These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26182190)

  • 1. Use of Aspirin for Prevention of Recurrent Atherosclerotic Cardiovascular Disease Among Adults — 20 States and the District of Columbia, 2013.
    Fang J; George MG; Hong Y; Loustalot F
    MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(27):733-7. PubMed ID: 26182190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aspirin use in patients with atherosclerotic cardiovascular disease: the 2016 Chinese expert consensus statement].
    ; ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):68-80. PubMed ID: 28056332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
    Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
    Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of low-dose aspirin as secondary prevention of atherosclerotic cardiovascular disease in US adults (from the National Health Interview Survey, 2012).
    Fang J; George MG; Gindi RM; Hong Y; Yang Q; Ayala C; Ward BW; Loustalot F
    Am J Cardiol; 2015 Apr; 115(7):895-900. PubMed ID: 25670639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin for Primary Atherosclerotic Cardiovascular Disease Prevention as Baseline Risk Increases: A Meta-Regression Analysis.
    Nudy M; Cooper J; Ghahramani M; Ruzieh M; Mandrola J; Foy AJ
    Am J Med; 2020 Sep; 133(9):1056-1064. PubMed ID: 32445718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Ischemic Stroke: Strategies for Prevention.
    Oza R; Rundell K; Garcellano M
    Am Fam Physician; 2017 Oct; 96(7):436-440. PubMed ID: 29094912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis.
    Kourlaba G; Fragoulakis V; Maniadakis N
    Appl Health Econ Health Policy; 2012 Jul; 10(4):261-71. PubMed ID: 22667992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
    Takahashi S; Mizuno O; Sakaguchi T; Yamada T; Inuyama L
    Adv Ther; 2014 Jan; 31(1):118-29. PubMed ID: 24385407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triflusal and aspirin in the secondary prevention of atherothrombotic ischemic stroke: a very long-term follow-up.
    Alvarez-Sabín J; Quintana M; Santamarina E; Maisterra O
    Cerebrovasc Dis; 2014; 37(3):181-7. PubMed ID: 24503927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic stroke in patients receiving aspirin.
    Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing cardiovascular disease in patients with diabetes: use of aspirin for primary prevention.
    Desai D; Ahmed HM; Michos ED
    Curr Cardiol Rep; 2015 Mar; 17(3):566. PubMed ID: 25676828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events.
    Calderone D; Ingala S; Mauro MS; Angiolillo DJ; Capodanno D
    Expert Rev Cardiovasc Ther; 2021 Dec; 19(12):1097-1117. PubMed ID: 34915778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulations.
    Logman JF; Heeg BM; Herlitz J; van Hout BA
    Appl Health Econ Health Policy; 2010; 8(4):251-65. PubMed ID: 20578780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Outpatient Cardiac Rehabilitation Among Heart Attack Survivors - 20 States and the District of Columbia, 2013 and Four States, 2015.
    Fang J; Ayala C; Luncheon C; Ritchey M; Loustalot F
    MMWR Morb Mortal Wkly Rep; 2017 Aug; 66(33):869-873. PubMed ID: 28837549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial.
    Marquis-Gravel G; Roe MT; Robertson HR; Harrington RA; Pencina MJ; Berdan LG; Hammill BG; Faulkner M; Muñoz D; Fonarow GC; Nallamothu BK; Fintel DJ; Ford DE; Zhou L; Daugherty SE; Nauman E; Kraschnewski J; Ahmad FS; Benziger CP; Haynes K; Merritt JG; Metkus T; Kripalani S; Gupta K; Shah RC; McClay JC; Re RN; Geary C; Lampert BC; Bradley SM; Jain SK; Seifein H; Whittle J; Roger VL; Effron MB; Alvarado G; Goldberg YH; VanWormer JL; Girotra S; Farrehi P; McTigue KM; Rothman R; Hernandez AF; Jones WS
    JAMA Cardiol; 2020 May; 5(5):598-607. PubMed ID: 32186653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
    Jamieson DG; Parekh A; Ezekowitz MD
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Would You Recommend Aspirin to This Patient for Primary Prevention of Atherosclerotic Cardiovascular Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Burns RB; Pignone M; Michos ED; Kanjee Z
    Ann Intern Med; 2021 Oct; 174(10):1439-1446. PubMed ID: 34633837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial.
    Hong KS; Kim BJ; Lee JY; Kwon SU;
    Int J Stroke; 2015 Oct; 10(7):1153-8. PubMed ID: 26044566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.